Abstract Forty-six of 47 patients diagnosed as having chronic fatigue and offered treatment four years previously were followed up. Twenty-nine patients were interviewed, three patients refused an inter-
Over the past decade much attention has been focused on the syndrome variously described as myalgic encephalomyelitis, postviral fatigue syndrome, and latterly chronic fatigue syndrome. This plethora of names and the frequency of descriptions is testament to the confusion surrounding the syndrome. The term chronic fatigue syndrome has been proposed to describe disabling fatigue of at least six months' duration of uncertain aetiology. [1] [2] [3] The cause of the syndrome remains to be determined, but there is a complex interaction between biological and psychological substrates.
A series of studies has shown that between 50 and 80% of subjects with chronic fatigue syndrome seen in specialist centres or primary care settings fulfil criteria for psychiatric disorders.49 Although reports of chronic fatigue can be found as far back as 1869 with Beard's description of neurasthenia or nervous exhaustion,'0 systematic studies of the disorder have only been undertaken in the past few years and therefore information about the natural history and the effects of treatment is limited. Anecdotal reports of a large series suggested an extremely gloomy natural history." A follow up study of subjects seen at an infectious disease clinic was only slightly more optimistic,'2 as most patients remained symptomatic two to four years after assessment. Treatment was not offered in either of these studies.
In this study we followed up a group of patients seen at the National Hospital for Neurology and Neurosurgery four years previously who had been diagnosed as having chronic fatigue.6 These patients were initially assessed before the current criteria for chronic fatigue syndrome became available, but most would have satisfied the criteria retrospectively; only two patients were excluded because of a life-long history of fatigue (that is, no definite onset).
These 47 patients were initially offered treatment in an open, uncontrolled trial using cognitive behaviour therapy. Antidepressants were offered to those patients who fulfilled diagnostic criteria for depression."3 Treatment followed cognitive behavioural principles derived from work on the management of chronic pain but adapted for the particular problems of chronic fatigue syndrome.'4 15 We decided to follow up this group of patients to determine if treatment gains were maintained, what happened to those who refused treatment, and to elucidate further the role of psychiatric morbidity in the prognosis of chronic fatigue syndrome.
Subjects and methods

SUBJECTS
Forty-six of the 47 subjects who took part in the original study were contacted by post four years later. The case notes of the remaining patient could not be traced. Those who did not respond to the initial letter were sent a second. Thirty-two (70%) patients responded (18 women, 14 men).
Of those who responded, 29 (91%) agreed to be interviewed. Nine (28%) were seen at home, 11 (34%) at the National Hospital for Neurology and Neurosurgery, and nine were interviewed by telephone. The general practitioners of the 14 patients who did not respond were contacted by telephone to obtain information about their physical and mental health during the follow up period.
INSTRUMENTS
Three questionnaires were sent by post when the patients were initially contacted. One was a fatigue questionnaire modified from that devised for the previous study.616 Scores ranged from 0 to 10; the higher the score the greater the fatigue. The results of the initial fatigue questionnaires were corrected to make the index scores and follow up scores directly comparable. The other two questionnaires were the General Health Questionnaire-(GHQ-1 2)'7 and the Hospital Anxiety and Depression (HAD) Questionnaire. '8 At follow up patients were classified as still having chronic fatigue syndrome if they fulfilled the following criteria: (a) Twenty two (76%) of these patients had accepted treatment when first seen and of these 17 had successfully completed it. Three patients discontinued treatment-and two patients felt no benefit at the completion of treatment. Seven of the patients seen at follow up had refused treatment when initially assessed.
SELF-RATED GLOBAL IMPROVEMENT
The 29 subjects were divided into two groups: group 1-those who felt no or only a slight improvement (< 50% score on the selfrated global improvement scale) (13 patients); and group II-those who felt they had recovered or almost recovered (> 50% score on the self-rated global improvement scale) (16 patients somatisation disorder (two patients), major depression (one patient), minor depression (one patient) and anxiety disorder (one patient). The difference between the groups is statistically significant (p < 0-05). Table 2 reports other differences between the two groups. Thus patients in the group with persisting chronic fatigue syndrome had a greater functional impairment, experienced greater somatic discomfort and had higher scores for anxiety and depression.
The ratings obtained during the initial assessment by those who fulfilled the criteria for chronic fatigue syndrome at follow up were compared with those of the rest of the group to ascertain possible differences of prognostic value (see table 3 ).
There was no difference in age of onset, sex, or duration of fatigue at index assessment between the two groups, nor was there any difference in the severity of depression as assessed by their BDI and HAD scores. Those who continue to have chronic fatigue syndrome at follow up, however, saw themselves as experiencing greater somatic discomfort and had significantly greater fatigue scores at the index assessment.
A change in the nature of the symptoms appeared to have taken place during the follow up period. Only five of the 10 patients who continue to fulfil the criteria for chronic fatigue syndrome felt that their current disorder was fatigue. Two patients felt that it was low mood, two reported poor concentration, and one patient felt it was recurrent chest pain due to angina. In contrast, at the initial When the general practitioner reports of the patients' current status were taken as evidence of the presence/absence of fatigue there was a significant association between completion of treatment and the absence of chronic fatigue syndrome at follow up. Thus from patient and general practitioner reports at four years, 20 (87%) of the 23 patients who successfully completed treatment remained well, whereas only two (13%) of the 16 who refused or did not complete treatment had made a spontaneous recovery.
Discussion
We acknowledge several shortcomings in this study. The number of subjects seen at follow up was smaller than in the original study and in the initial study the treatment group was uncontrolled and therefore non-blind and non-randomised. Nevertheless it is hoped that the findings presented here will shed some light on the long-term prognosis of chronic fatigue syndrome and the long-term effects of treatment of a kind which is now commonly used in these patients.
Patients were reassessed four years after they had been seen at the National Hospital for Neurology and Neurosurgery and diagnosed as having chronic fatigue. In the initial follow up"3 70% of the group who accepted treatment described themselves as 'better' or 'much better' when treatment was completed and at three months this had been sustained. Follow up at four years continues to show that treatment benefits are being maintained. There was a trend for the initial treatment response to be associated with the continued absence of chronic fatigue syndrome at four years. This reached conventional statistical significance when general practitioner assessments of current functioning were included.
We therefore conclude that there is a strong association between successful completion of treatment and the absence of functional disability at the four year follow up.
Those patients who continued to be impaired at follow up had marked functional disabilities resulting in long-term unemployment and continuing costs to their health services. The issue of disability payments for patients with chronic fatigue syndrome is currently receiving attention and is the subject of controversy. Our results highlight the longterm benefits that may result from treatment. As treatment in the original study was nonrandom and all patients were offered cognitive behaviour therapy, with only those who were considered to be depressed offered antidepressants, we are unable to discuss the relative merits of cognitive behaviour therapy versus treatment with antidepressants. A randomised controlled trial of cognitive behaviour therapy by two of the authors (TC and SW) is nearing completion, however, and it is hoped that more information on this subject will soon be available.
One of the salient findings of our study is that at four years just over one third of our sample continues to fulfill the criteria for chronic fatigue syndrome. This is similar to the findings of Sharpe et al. 24 In their study these workers followed up a group of 144 patients seen in an infectious disease clinic with a major disorder of fatigue of at least six weeks' duration. No treatment was offered.
They found that a third of patients remained impaired at two to four years compared with 73% followed up at six weeks to six months after the initial assessment. The prognosis of severe chronic fatigue syndrome appears to be associated with psychiatric morbidity and in particular depression. Eight of the nine patients in our series who had a current RDC diagnosis of depression fulfilled the criteria for current chronic fatigue syndrome; on the other hand, the three patients who had RDC diagnoses other than depression did not have chronic fatigue syndrome.
In descriptive terms many of the symptoms that are accompanied by chronic fatigue syndrome are similar to those of depression. It has been suggested that severe chronic fatigue syndrome and severe depression are largely indistinguishable in their symptom profiles.27 Several reviews have discussed these dilemmas828 and it remains difficult to disentangle the "cause and effect" conundrum associating the two. It has been postulated that in some patients persistent fatigue may be initiated by an acute viral infection with its usual symptoms of transient lassitude and malaise, which are then perpetuated in the psychologically vulnerable by relevant psychological factors. '9 Another possibility is that patients who fulfill the criteria for chronic fatigue syndrome have a psychiatric illness which predominantly manifests as fatigue. In favour of this is the fact that many depressed patients often report physical symptoms similar to those of chronic fatigue syndrome. The presence of a psychiatric disorder before the presentation of fatigue would be consistent with this.
The presence of a psychiatric diagnosis before and after the development of 
